Skip to main content
OpenTrials

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,259 public trials 4,410 recruiting studies
Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

NCT02991469

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations
  • Investigational Site Number : 0320004 San Miguel de Tucumán, Tucumán Province, Argentina
  • Investigational Site Number : 0320005 Buenos Aires, Argentina
  • Investigational Site Number : 1240110 Calgary, Alberta, Canada
  • Investigational Site Number : 2460040 Helsinki, Finland
View all 37 locations
View Trial Details
Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

NCT05827081

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +5 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Western Reg MC-COH Phoenix Goodyear, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
View all 229 locations
View Trial Details
Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT03816345

Conditions
Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 52 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT06618287

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center Miami, Florida, United States
  • Local Institution - 0065 Iowa City, Iowa, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View all 65 locations
View Trial Details
Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

NCT07085767

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Clinical Trial Site Hot Springs, Arkansas, United States
  • Clinical Trial Site Beverly Hills, California, United States
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Los Alamitos, California, United States
View all 200 locations
View Trial Details
Recruiting

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Genital Diseases, +28 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details

Related conditions